Class 4 medicine recallMedicine · 28 May 2020
Torbay Pharmaceuticals has informed us that the carton label on Sodium Benzoate (Amzoate) 2g in 10 mL Sterile Solution for injection incorrectly states the concentration of disodium edetate (excipient) as 0.1% w/v (10mg in…
Medicine recallMedicine · 27 May 2020
As a precautionary measure, Pfizer Limited is recalling the above batches from wholesalers due to out of specification results from the ongoing stability studies. An evaluation of the foil laminate pouch identified oxygen levels…
Class 2 medicine recallHigh riskMedicine · 12 May 2020
Pharmaswiss Česka republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of Emerade 500 microgram auto-injectors (also referred to as pens) from patients due to an error in…
Class 4 medicine recallMedicine · 20 Apr 2020
GSK has informed us that due to a machinery defect with the printing line, a small number of packs may not have the batch number and expiry date printed on the outer cartons. The…
Class 4 medicine recallMedicine · 16 Apr 2020
TEVA UK Limited has informed us that the Product Code/GTIN (PC) number found on the below batches is incorrect.
Medical device alertMedicine · 10 Apr 2020
All manufacturers – there have been reports of off-label modifications to haemofiltration systems when treating Covid-19 patients leading to serious injury and death.
Medical device alertMedicine · 8 Apr 2020
All anaesthesia machines with ventilators - using the anaesthesia device in treatment of critical illness, outside its intended use is considered off-label use but may be essential due to ventilator availability.
Class 2 medicine recallHigh riskMedicine · 7 Apr 2020
Pharmaswiss Česka republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of Emerade 300 microgram auto-injectors (also referred to as pens) from patients due to an error in…
Class 4 medicine recallMedicine · 30 Mar 2020
Rosemont Pharmaceuticals Ltd has informed us of an error in the barcode and GTIN number of the label on the bottle of the below batches.
Class 4 medicine recallMedicine · 19 Mar 2020
The MHRA is currently investigating an incident where several medicines appear to have left the legal supply chain and have then been re-introduced via WDA(H) 50340 HMS Wholesale Limited. This License has now been…
Class 2 medicine recallHigh riskMedicine · 18 Mar 2020
Gedeon Richter (UK) Ltd is recalling all unexpired stock of Esmya 5 mg tablets from patients, pharmacies and wholesalers following a new case of liver failure requiring liver transplant in a patient taking the…
Class 4 medicine recallMedicine · 11 Mar 2020
Mylan UK Healthcare Ltd has informed us that a product complaint has been received relating to crystalline precipitate being observed during bottle use. Due to concerns with continuity of supply these batches are not…
Class 2 medicine recallHigh riskMedicine · 4 Mar 2020
Pharmaswiss Česka republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of Emerade 150 microgram auto-injectors (also referred to as pens) from patients due to an error in…
Class 2 medicine recallHigh riskMedicine · 2 Mar 2020
AOP Orphan Pharmaceuticals AG is recalling all unexpired stock of a batch of Tetrabenazine 25 mg tablets (from pharmacies and wholesalers) as a precautionary measure due to out of specification results for the assay,…
Medical device alertMedicine · 27 Feb 2020
Manufactured by Cardinal Health – calibration period revised to 25 weeks instead of yearly to ensure these thermometers remain within their accuracy range and reduce the risk of misdiagnosis or delay in treatment.
Class 4 medicine recallMedicine · 27 Feb 2020
G.L Pharma GmbH T/A Healthcare Pharma Ltd has informed us that the Patient Information Leaflet (PIL) within the packs for the specified batches is missing important safety relevant text changes.
Class 4 medicine recallMedicine · 25 Feb 2020
Crescent Pharma Ltd has informed us of a discrepancy on the product packaging.
Class 4 medicine recallMedicine · 24 Feb 2020
Crescent Pharma Ltd and Flamingo Pharma (UK) Ltd have informed us that the Patient Information Leaflet (PIL) within their packs for the above pharmacy (P) batches is incorrect.
Class 4 medicine recallMedicine · 17 Feb 2020
Accord Healthcare Ltd has informed us of an issue related to the expiry date for the above batches, which has not been encoded in 2D data matrix.
Class 2 medicine recallHigh riskMedicine · 13 Feb 2020
Accord-UK Limited is recalling all unexpired stock of Gliclazide 40 mg Tablets (Northstar Livery) from pharmacies and wholesalers as a precautionary measure due to out of specification results for dissolution, obtained during routine stability…
Class 3 medicine recallMedicine · 12 Feb 2020
Glaxo Wellcome UK Ltd T/A GSK has informed us of an issue related to error in the decommissioning of the K84X batch.
Class 4 medicine recallMedicine · 12 Feb 2020
Accord Healthcare Ltd has informed us that the Patient Information Leaflet (PIL) for all strengths of Atrolak XL Prolonged-release tablets is missing the side effects identified from post-marketing experience.
Medicine recallMedicine · 6 Feb 2020
Glenmark Pharmaceuticals is recalling specific batches as a precautionary measure.
Class 2 medicine recallHigh riskMedicine · 3 Feb 2020
Medreich Plc is recalling all unexpired stock of the above products from pharmacies and wholesalers as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.